RTOG 0625: A phase II study of bevacizumab with irinotecan in recurrent glioblastoma (GBM)
Article
Gilbert, MR, Wang, M, Aldape, K et al. (2009). RTOG 0625: A phase II study of bevacizumab with irinotecan in recurrent glioblastoma (GBM)
. JOURNAL OF CLINICAL ONCOLOGY, 27(15_suppl), 2011-2011. 10.1200/jco.2009.27.15_suppl.2011
Gilbert, MR, Wang, M, Aldape, K et al. (2009). RTOG 0625: A phase II study of bevacizumab with irinotecan in recurrent glioblastoma (GBM)
. JOURNAL OF CLINICAL ONCOLOGY, 27(15_suppl), 2011-2011. 10.1200/jco.2009.27.15_suppl.2011